Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.44
+0.61006.91%
Pre-market: 9.490.0500+0.53%04:58 EDT
Volume:27.29M
Turnover:263.21M
Market Cap:10.00B
PE:-9.55
High:10.09
Open:8.92
Low:8.90
Close:8.83
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:2.87
T/O Rate:6.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-9.56
PE(LYR):-24.71

Loading ...

Why Is ImmunityBio Stock Rallying Thursday?

Benzinga Earnings
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)

TIPRANKS
·
Apr 10

ImmunityBio Reports Preliminary Q1 Net Product Revenue

MT Newswires Live
·
Apr 09

Immunitybio Inc - Preliminary Q1 2026 Net Product Revenue $44.2 Mln, up 168% Year-Over-Year

THOMSON REUTERS
·
Apr 09

Press Release: ImmunityBio Reports Net Product Revenue Increased Nearly 2.7 Times Year-Over-Year to Record $44 Million in Q1 2026 and $381 Million in Cash and Marketable Securities

Dow Jones
·
Apr 09

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 08

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

Reuters
·
Apr 06

BUZZ-U.S. STOCKS ON THE MOVE-Legence, Valero Energy, Stereotaxis

Reuters
·
Apr 06

BRIEF-Immunitybio Addresses FDA Correspondence And Reaffirms Commitment To Advertising Compliance

Reuters
·
Apr 06

Immunitybio Inc - Initiates Review and Implements Enhanced Advertising Compliance Measures

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Removes Identified Podcast and Requests Removal From Third-Party Platforms

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Submits Response to FDA Opdp Regarding Promotional Issues Raised on March 13, 2026

THOMSON REUTERS
·
Apr 06

Immunitybio Inc - Implements Corrective Actions Including Executive Training and External Regulatory Counsel

THOMSON REUTERS
·
Apr 06

Immunitybio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance

THOMSON REUTERS
·
Apr 06

ImmunityBio says FDA-cited TV ad never aired, pulls podcast after OPDP letter

Reuters
·
Apr 06